openPR Logo
Press release

Adenosine 5-Monophosphate Activated Protein Kinase (AMPK) Modulators Therapeutics Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations

04-03-2019 02:46 PM CET | Health & Medicine

Press release from: Pharma Proff

Adenosine 5-Monophosphate Activated Protein Kinase (AMPK)

Adenosine 5-monophosphate activated protein kinase (AMPK) plays an important role in regulation of homeostasis. Dysregulation of AMPK can result in many diseases which includes obesity and type 2 diabetes. Several studies have also suggested that AMPK are also associated with the development of neurological diseases and cancer.

Download the sample report @ https://www.pharmaproff.com/request-sample/1172

Despite of many advancements in the development of anti-cancer therapies, cancer is still one of the major causes of deaths, globally. AMPK is one of the newest targets for the anti-cancer therapies, which modulates cellular protein and lipid metabolism, affecting the cellular growth and division. The importance of AMPK mediate signalling in various diseases and its complexity suggested that there is an urgent need for the development of additional AMPK modulators that can be used to not only disturb the mechanism of action but also as a drug candidate for therapeutic development. Also, researches have demonstrated that, in-depth knowledge and evidences are required to produce desired physiological outcomes by developing specific targeted therapies with reduced adverse events and better efficacy.

Get the detailed analysis @ https://www.pharmaproff.com/report/ampk-modulators-therapeutics

Esperion Therapeutics Inc. is in the process of developing Bempedoic acid as a small molecule which acts as an AMPK stimulant for the treatment of hypercholesterolemia, dyslipidaemia, and hypertension. Betagenon AB, Boehringer Ingelheim International GmbH, and Poxel SA are some other companies having pipeline AMPK modulators for the management of several diseases.

Make enquiry before purchase @ https://www.pharmaproff.com/enquiry/1172

• The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with detailed analysis of pipeline and clinical trials.
• Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology and others.

About Us:
Pharma Proff, is a frontline market intelligence and consulting solutions provider catering to the information and data needs of burgeoning sectors across the world, including pharmaceutical and healthcare. With meticulously curated research reports on the industry landscape, we empower companies in the healthcare and pharmaceutical sectors to make informed business decisions and base their marketing strategies with astuteness.

Contact:
Pharma Proff
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@pharmaproff.com
Web: https://www.pharmaproff.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Adenosine 5-Monophosphate Activated Protein Kinase (AMPK) Modulators Therapeutics Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations here

News-ID: 1686040 • Views:

More Releases from Pharma Proff

Interleukin-6 (IL-6) Inhibitors Analysis, Clinical Trails and Developments
Interleukin-6 (IL-6) Inhibitors Analysis, Clinical Trails and Developments
Interleukin-6 (IL-6) inhibitors currently exhibit a proliferating pipeline with 25+ therapeutic candidates. IL-6 is a cytokine encoded by IL-6 gene, which helps in the maturation of B cells and is actively involved in the inflammatory response. The IL-6 protein is primarily produced at the sites of acute and chronic inflammation, where it is secreted into the serum and brings a transcriptional inflammatory response through IL-6? receptor. This protein is assumed to
Retinitis Pigmentosa Therapeutics Analysis, Clinical Trials and Other Developments
Retinitis Pigmentosa Therapeutics Analysis, Clinical Trials and Other Developmen …
Retinitis pigmentosa therapeutics currently exhibits a proliferating pipeline with 25+ therapeutic candidates. Retinitis pigmentosa (RP) is a group of hereditary disorders that lead to the breakdown and loss of cells in the retina. Mutation in genes encoding the proteins required by retinal cells for their proper functioning, results in occurrence of RP. The disease results in partial vision loss during the earlier stage of the disease, which may lead to complete
Probiotics Therapeutics -Pipeline Analysis 2018, Clinical Trials & Results, Pate …
Probiotics are live microorganisms that produces beneficial effects in human gut. Probiotics can be taken as a dietary supplement. They prevent diarrhoea and help to reduce the symptoms of irritable bowel syndrome. Download the sample report at: https://www.pharmaproff.com/request-sample/1189 Probiotics comprise of a variety of microorganisms belonging to the Lactobacillus and Bifidobacterium groups. The only yeast probiotic that has proven to be effective is Saccharomyces boulardii. According to researchers, probiotics are effective in
Niemann-Pick Disease Type C (NPC) Therapeutics Pipeline to Witness Significant Growth due to Increasing Strategic Developments in the Coming Years | Top Players are Orphazyme A/S, IntraBio Ltd., CTD Holdings, Inc., Mallinckrodt Pharmaceuticals, SOM Biotec
Niemann-Pick Disease Type C (NPC) Therapeutics Pipeline to Witness Significant G …
Niemann-Pick disease is divided into four main types: type A, type B, type C1, and type C2. These types are classified on the basis of genetic cause and signs and symptoms of the disease. NPC is identified as a rare genetic disorder in which the body is unable to transport cholesterol and lipids inside the cells. This causes accumulation of these substances within various tissues of the body. These substances

All 5 Releases


More Releases for AMPK

New Report: Adiponectin Antibody Market 2022 Size, Growth Analysis Report, Forec …
The global adiponectin antibody market is anticipated to grow at a CAGR of 6.2% during the forecast period (2022-2028). Growing demand for adiponectin antibody in Enzyme Linked Immunosorbent Assay (ELISA) and western blotting analysis is driving the growth of the adiponectin antibody market. Adiponectin is a lipid and glucose metabolism-regulating protein hormone released primarily by adipocytes. Adiponectin has been linked to a variety of physiological functions, including homeostasis and obesity.
CD BioSciences Launches Metabolic Signaling Pathways for Research Use
CD BioSciences, a US-based life science research product supplier and CRO, recently introduces a comprehensive panel of metabolic signaling pathways to the life science community for research uses, such as insulin signaling pathway, mTOR pathway, and AMPK pathway. Metabolism describes the life-sustaining chemical reactions in an organism. It can be divided into two categories: catabolism, the breakdown of molecules, and anabolism, the synthesis of molecules. Metabolism is closely related to the
Global Dorsomorphin Dihydrochloride Market, Size, Share, Analysis Report & Forec …
The global dorsomorphin dihydrochloride market is anticipated to grow at a significant CAGR during the forecast period. Dorsomorphin dihydrochloride (BML-275 dihydrochloride; Compound C dihydrochloride) is an AMPK inhibitor with a Ki of 109 nM that is potent, selective, and ATP-competitive. Dorsomorphin dihydrochloride inhibits the BMP pathway by binding to the ALK2, ALK3, and ALK6 type receptors. Autophagy is induced by dorsomorphin dihydrochloride. In vitro, it stimulates cardiomyogenesis in mouse embryonic
CarboFix Reviews: Legit Weight Loss Supplement or SCAM?
Visit Offical Website >> https://bit.ly/3kavliN CarboFix is a weight loss supplement that improves metabolism and reduces appetite while controlling blood sugar levels. While many of the benefits are related directly to weight and appetite, the remedy's creators also state that it helps with longevity, helps boost metabolism, and controls blood sugar levels. Cultures worldwide have developed their holistic methods to treat nearly any disease, and one of those diseases is obesity. The
Employee Feedback Platform Market Demand and Key Players by 2024:15Five, Culture …
Global Employee Feedback Platform Market Growth Status and Outlook 2019-2024 Employee Feedback Platform is a platform that can help improve employee engagement, retention and productivity. This report presents a comprehensive overview, market shares and growth opportunities of Employee Feedback Platform market by product type, application, key companies and key regions. Get Sample Copy Of this report:  https://www.reportsweb.com/inquiry&RW00012536717/sample Companies Profiled in this report includes: 15Five, Culture Ampk, TinyPulse, Weekdone, Impraise, Achievers, Reflektive, Peakon, Glint, Saba
Cell Signaling Market Report 2018: Segmentation by Type (Endocrine, Paracrine, O …
Global Cell Signaling market research report provides company profile for Merck KGaA (Germany), Becton, Dickinson and Company (U.S.), Beckman Coulter, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), QIAGEN N.V. (Netherlands), PerkinElmer Inc. (U.S.) and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue,